Viracta Therapeutics Inc (VIRX)
0.8001
-0.01
(-1.25%)
USD |
NASDAQ |
May 06, 16:00
0.79
-0.01
(-1.26%)
After-Hours: 20:00
Viracta Therapeutics Shareholders Equity (Quarterly): 18.32M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.32M |
| September 30, 2023 | 30.01M |
| June 30, 2023 | 40.78M |
| March 31, 2023 | 51.11M |
| December 31, 2022 | 61.10M |
| September 30, 2022 | 67.81M |
| June 30, 2022 | 77.00M |
| Date | Value |
|---|---|
| March 31, 2022 | 85.60M |
| December 31, 2021 | 94.37M |
| September 30, 2021 | 103.98M |
| June 30, 2021 | 117.10M |
| March 31, 2021 | 124.74M |
| December 31, 2020 | -46.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-46.20M
Minimum
Dec 2020
124.74M
Maximum
Mar 2021
63.52M
Average
67.81M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| XOMA Corp | 88.72M |
| Marinus Pharmaceuticals Inc | 16.76M |
| Cartesian Therapeutics Inc | -440.18M |
| Adial Pharmaceuticals Inc | 4.084M |
| NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.69M |
| Total Liabilities (Quarterly) | 38.37M |